Former President and Chief Executive Officer · Traws Pharma, Inc. (TRAW)

Steven Fruchtman

A named executive officer of Traws Pharma in every fiscal year CompBrief holds from FY2017 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$410,000

Salary $332,887Stock awards $0

FY2023: $1,106,747

4th of 4 named executive officers at Traws Pharma by FY2024 total.

4 named officers on file for Traws Pharma, FY2024

Steven Fruchtman’s pay file — $29

  • 8 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Traws Pharma’s whole pay program stands against its peers

  • Traws Pharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TRAW→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 8, 2025 (DEF 14A).

Free

Get Steven Fruchtman’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Steven Fruchtman compensation by year

Traws Pharma Summary Compensation Table · all 8 fiscal years held
In US dollars, as Traws Pharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Salary$436,154$460,840$509,215$562,224$600,000$630,000$660,894$332,887
Bonus$0$322,304$191,452$266,705$279,750$251,769$227,391$0
Stock awards$0$0$0$118,173$1,261,685$116,407$50,613$0
Option awards$49,105$164,361$50,000$61,507$509,079$302,516$131,662$0
Non-equity incentive$0$0$0$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0$0$0$0
All other$19,315$22,580$21,846$23,214$23,699$26,090$36,187$77,113
Total$504,574$970,085$772,513$1,031,823$2,674,213$1,326,782$1,106,747$410,000

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Traws Pharma, Inc. DEF 14A filed October 8, 2025, accession 0001104659-25-097926, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Traws Pharma, Inc. filed document, accession 0001104659-25-097926. Every figure is read from that document and cited to the page and table it appears in. Filed October 8, 2025.

$505K
$970K
$773K
$1.0M
$2.7M
$1.3M
$1.1M
$410K
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU69,333$51,695—
PSU47,065$35,299—
RSU42,640$31,792—
RSU12,567$9,370—
Option2,824——
Option25,112—$5.19
Option76,620—$1.82
Option207,000—$0.73

Per the Outstanding Equity Awards at Fiscal Year-End table in Traws Pharma, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Traws Pharma’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Werner CautreelsFormer Chief Executive Officer$647,582
Mark GuerinFormer Chief Financial Officer and Chief Operating Officer$562,747
Victor MoyoChief Medical Officer – Oncology$478,436
Steven Fruchtman · this pageFormer President and Chief Executive Officer$410,000

The full Traws Pharma compensation record

free company brief

This page is one person within Traws Pharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Traws Pharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Steven Fruchtman's compensation dossier · One-time report. No refunds.